Requirements: 1. Renowned domestic and international experts with high reputation. 2. High academic status in tumor big data mining and artificial intelligence deep learning. 3. Rich experience in tumor clinical research and epidemiology. 4. Expert recommendation: Professor Ji Jianguang from the Clinical Research Center of Lund University in Sweden. Benefits: 1. Transportation expenses such as round-trip airfare. 2. Accommodation and meals during your stay in China. 3. Lectures and labor costs. 4. Reasonable salary

Requirements: 1. Renowned domestic and international experts with high reputation. 2. High academic status in the field of otolaryngology and head and neck surgery. 3. Experienced experts in the application of digital and navigation technology after surgery for head and neck tumors. Recommendation: Professor Dr. FriedrichBootz, Director of the Otolaryngology Center at the University of Bonn, Germany. Benefits: 1. Transportation expenses such as round-trip air tickets. 2. Accommodation and meals during your stay in China. 3. Lectures and labor costs

Engaged in basic and clinical research on stem cells, and engaged in basic and clinical research on cardiovascular and cerebrovascular diseases. Professor SanbingShen from the School of Medicine at the University of Galway in Ireland has a good foundation in collaborative research with us.

1. PeterWiklund, Department of Urology, Karolinska University Hospital, SE-17176, Stockholm, Sweden2. KariHeminki, GermanCancerResearchCenter. Molecular and Genetic Epidemiology of Cancer. 3. JesperLagergren, Karolinska Institute, stomachandesophagealcancer, Sweden4. ClaesGustafsson, Univer1. Visiting professor allowance is RMB 10000 to 15000 per person per month, paid based on actual working hours. The performance allowance shall be paid by the research group (or department, hospital) based on the approved project or project situation. 2. Provide temporary housing for free. 3. Provide necessary laboratory and office space. 4. Provide round-trip travel expenses to our hospital every year according to work needs.

1. Professor Torsten Mueller, Hohenheim University, Germany. Mainly conducting research on the optimization of phosphorus resources in the grain feed energy system, mainly based on corn. 2. Jean Beigbeder, a French maize breeding expert. He has worked in corn breeding related fields at internationally renowned seed companies such as Lima Grande Seed Company in France, Pioneer Seed Company in the United States, and Syngenta Seed Company, and has a wealth of corn breeding theory and experience. Please come to our company, Jean Beigbeder, to tell us about the three major temperate corn belts in the world: the United States, Europe, and China, with illustrations and text. And based on this, the differences in the correlation between corn maturity, rainfall, yield and other factors in three places were analyzed. Taking major international seed companies as examples, we clearly identified the reasons for the differences. Combined with the current situation of corn breeding in Europe, and facing the competitive pressure of the global seed industry market, we pointed out China's corn breeding strategy and technical route. 3. Dr. Joachim Kramer, an Austrian maize breeding expert. Dr. Joachim Kramer has been engaged in research on maize breeding for a long time. I worked at a German seed company from 1971 to 1986, and then at Pioneer in the United States for 23 years, with extensive experience in maize breeding. He proposed future breeding directions: breeding new maize varieties with high yield, high density tolerance, lodging resistance, disease resistance, fast grain dehydration rate, and suitability for mechanized grain harvesting. At the same time, Dr. Joachim Kramer made a profound analysis and explanation on the improvement and innovation of germplasm resources, especially on the introduction of foreign maize germplasm from Europe and the United States. He invited him to China, and would certainly put forward good suggestions and opinions on China's maize breeding, especially our company's maize breeding, and asked him to tell us about the improvement methods of inbred lines with good traits, parent selection of strong heterosis combinations Conservation and utilization of germplasm resources in Europe and the United States. Further improve the theoretical level of maize breeding in China and accelerate the process of maize breeding.

The First Hospital of Hebei Medical University has established a dedicated office with one permanent staff member, whose job responsibilities include scientific research coordination, technical guidance services, and daily reception. Responsible for liaising and ensuring work. Funds are allocated annually for workstation research, clinical operation, and management. A dedicated person is responsible for the accommodation, itinerary, and domestic arrangements of foreign experts.

1. Has a strong sense of professionalism and dedication, adheres to academic ethics, has a correct academic style, rigorous academic research, and has good personal qualities and medical ethics. 2. Has strategic thinking and profound academic expertise in the field of psychological counseling and treatment, with significant academic influence in the international academic community. 3. Experts and scholars who hold senior professional and technical positions in psychological counseling and treatment in renowned foreign universities and research institutes. 4. They have solid theoretical foundation, exquisite business skills, and strong business training abilities. 5. Provide accommodation for physical health and ensure that the salary level is not lower than that of Germany during the same period.

In recent years, our company has actively introduced international professional talents to form a dedicated team to prepare for the EU GMP certification. We successfully passed the EU certification on-site audit in July 2018 and obtained the EU GMP certification certificate in November 2019. In September 2017, Dutch expert Marco Albada Jelgersma was hired as the EU quality auditor. Mr. Marco is a senior pharmacist and EU regulatory consultant in the EU. Mr. Marco carefully understands the current production status, laboratory experiments, GMP document writing progress, and provides technical services and professional technical guidance for the accuracy, timeliness, and completeness of our company's production, operation, and confirmation. In September 2017, Dr. Fang, an American expert who was a former FDA auditor and had extensive experience in GMP in the United States and the European Union, was introduced. After many communications, the expert conducted a gap analysis on the current situation of our company and American and European standards, comprehensively and systematically evaluated the GMP work preparation, proposed the assessment of the problems and defects in the current work, and proposed the implementation plan to improve and strengthen GMP management in the future, so as to promote our company to pass the EU certification successfully. In April 2018, in order to ensure the smooth passage of the EU official audit, LUCIANOMASSIANTONIO was hired to conduct a phased work audit. This audit was conducted in full accordance with the requirements of on-site GMP inspections in Europe and America, recording the compliance of personnel with the implementation of GMP regulations in Europe and America under various dynamic conditions. At the same time, conduct in-depth and detailed checks on the compliance of current GMP documents and records in different modules. The expert clearly stated that at the current level, our company's software and hardware have basically met the GMP requirements of the European Union and FDA, strengthening our confidence in passing the official on-site audit of the European Union at once. In July 2018, JOANNAEWAMANIA was hired as our company's EU quality auditor. She is a senior pharmaceutical consultant in the EU. Through this consulting work, we will confirm that the project meets EU regulatory requirements and welcome the formal on-site audit. She went deep into the workshop and pointed out the existing problems and areas for improvement. In terms of product registration in Europe, we also carefully explain the requirements of EU regulations. JOANNA's attitude of striving for excellence has left a deep impression on our employees and reflects the severity of the drug production process in EU countries. From July 16th to 20th, 2018, our company received a 5-day rigorous and meticulous inspection of the software and hardware systems by the Portuguese official GMP prosecutor. The four prosecutors unanimously believed that our company's quality management system was sound and had met the inspection requirements for EU GMP certification. In November 2019, Italian experts ANGELOCONSOLARO and BRUNOXOMPERO were introduced. These two experts have years of development experience in the field of blowing, filling, and sealing equipment. Through multiple communications and exchanges, as well as on-site guidance and careful training for our company's technical personnel, they conducted in-depth and detailed inspections in modules, enabling our company's technical personnel to grasp the operation of the equipment. The expected results have been achieved, and the software and hardware aspects of the device have been further improved. In the future, our company will continue to implement talent introduction projects, introduce foreign experts, guide and promote the entry of anti-tumor drug products into the international market.

R&D Director

1、 Basic Introduction of the Enterprise Hebei Luxide Biotechnology Co., Ltd. is located in the Industrial Development Zone of Shenzhou City, Hebei Province. It was established in 2013 with a registered capital of 10 million yuan and covers an area of over 60 acres. The company is adjacent to Shihuang Expressway and 307 National Highway to the south, Daguang Expressway and Beijing Kowloon Railway Line to the east, and Hengbao Road to the west, providing convenient transportation for the company's products to be shipped nationwide. Hebei Luke Xide Biotechnology Co., Ltd. is a high-tech private enterprise specializing in the research, production, and sales of probiotics. 2、 We plan to introduce expert talents. Our company is preparing to introduce Professor Jiang Sixu's student, postdoctoral Liu Rui. Currently, he is a researcher at Gyeonggi do University in South Korea and our company's full-time technical director. He is responsible for deepening research on the application of lactic acid bacteria with antibacterial and antiviral active ingredients in the field of animal husbandry. We are preparing to apply for a new type of non antibiotic feed additive to replace antibiotics. In response to the national call for a comprehensive ban on antibiotics on July 1, 2020, we are applying for a Class II new feed additive from the Ministry of Agriculture.